A detailed history of Ubs Asset Management Americas Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 53,514 shares of CDNA stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,514
Holding current value
$1.15 Million
% of portfolio
0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$14.41 - $33.99 $771,136 - $1.82 Million
53,514 New
53,514 $1.67 Million
Q3 2023

Nov 13, 2023

BUY
$7.0 - $11.26 $50,204 - $80,756
7,172 Added 9.78%
80,489 $563,000
Q1 2023

May 15, 2023

BUY
$8.83 - $17.61 $223,981 - $446,695
25,366 Added 52.9%
73,317 $670,000
Q4 2022

Feb 14, 2023

SELL
$10.88 - $20.05 $29,756 - $54,836
-2,735 Reduced 5.4%
47,951 $547,000
Q3 2022

Nov 14, 2022

SELL
$16.06 - $26.39 $25,583 - $42,039
-1,593 Reduced 3.05%
50,686 $862,000
Q2 2022

Aug 12, 2022

SELL
$20.49 - $39.72 $236,557 - $458,567
-11,545 Reduced 18.09%
52,279 $1.12 Million
Q1 2022

May 16, 2022

BUY
$28.19 - $46.6 $431,109 - $712,653
15,293 Added 31.51%
63,824 $2.36 Million
Q4 2021

Feb 14, 2022

SELL
$41.2 - $73.6 $9.82 Million - $17.5 Million
-238,241 Reduced 83.08%
48,531 $2.21 Million
Q3 2021

Nov 15, 2021

SELL
$59.15 - $91.99 $284,393 - $442,287
-4,808 Reduced 1.65%
286,772 $18.2 Million
Q2 2021

Aug 16, 2021

SELL
$63.02 - $95.11 $852,660 - $1.29 Million
-13,530 Reduced 4.43%
291,580 $26.7 Million
Q1 2021

May 14, 2021

SELL
$57.62 - $95.6 $335,521 - $556,678
-5,823 Reduced 1.87%
305,110 $20.8 Million
Q4 2020

Mar 01, 2021

SELL
$41.43 - $77.09 $3.52 Million - $6.55 Million
-84,931 Reduced 21.45%
310,933 $22.5 Million
Q3 2020

Nov 13, 2020

BUY
$30.88 - $37.94 $20,844 - $25,609
675 Added 0.17%
395,864 $15 Million
Q2 2020

Aug 14, 2020

BUY
$18.95 - $35.43 $6.94 Million - $13 Million
366,311 Added 1268.48%
395,189 $14 Million
Q1 2020

May 15, 2020

SELL
$13.94 - $28.25 $12,434 - $25,199
-892 Reduced 3.0%
28,878 $630,000
Q4 2019

Feb 14, 2020

SELL
$19.24 - $28.41 $78,056 - $115,259
-4,057 Reduced 11.99%
29,770 $642,000
Q3 2019

Nov 14, 2019

BUY
$20.03 - $40.08 $186,939 - $374,066
9,333 Added 38.1%
33,827 $764,000
Q2 2019

Aug 15, 2019

BUY
$25.78 - $39.77 $82,496 - $127,264
3,200 Added 15.03%
24,494 $0
Q1 2019

May 14, 2019

BUY
$22.09 - $39.21 $189,841 - $336,970
8,594 Added 67.67%
21,294 $0
Q4 2018

Feb 13, 2019

BUY
$19.89 - $30.02 $252,603 - $381,254
12,700 New
12,700 $319,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.